Epidemiology of Hypertension

Hypertension: A Companion to Braunwald's Heart Disease

Volumn , Issue , 2007, Pages 3-14

  Lloyd Jones, Donald M ^a,b   Levy, Daniel ^c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349461684     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3053-9.50007-X     Document Type: Chapter

References (54)

1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
2. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension 2004, 44:398-404.
3. Hill AB The environment and disease: Association or causation?. Proc R Soc Med 1965, 58:295-300.
4. Hennekens CH, Buring JE Epidemiology in Medicine 1987, Little, Brown, Boston.
5. Glover MJ, Greenlund KJ, Ayala C, Croft JB Racial/ethnic disparities in prevalence, treatment, and control of hypertension: United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005, 54:7-9.
6. Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult us population: Data from the health examination surveys, 1960 to 1991. Hypertension 1995, 26:60-69.
7. Hajjar I, Kotchen TA Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003, 290:199-206.
8. American Heart Association Heart Disease and Stroke Statistics: 2005 update 2004, American Heart Association, Dallas, TX.
9. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004, 43:10-17.
10. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369.
11. Mackay J, Mensah G Atlas of Heart Disease and Stroke 2004, World Health Organization, Geneva, Accessed May 6, 2005. http://www.who.int/cardiovascular_diseases/resources/atlas/en/print.html .
12. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet 2005, 365:217-223.
13. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002, 287:1003-1010.
14. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
15. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study. Circulation 1997, 96:308-315.
16. Lakatta EG, Levy D Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part I. Aging arteries: A "set up" for vascular disease. Circulation 2003, 107:139-146.
17. Izzo JL, Levy D, Black HR Importance of systolic blood pressure in older Americans. Hypertension 2000, 35:1021-1024.
18. Wang Y, Wang QJ The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines. Arch Intern Med 2004, 164:2126-2134.
19. Wilson PWF, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 2002, 162:1867-1872.
20. Lloyd-Jones DM, Liu K, Colangelo LA, et al. Consistently stable body mass index and changes in risk factors associated with the metabolic syndrome: The CARDIA study [abstract]. Circulation 2004, 110(Suppl III):I1-I772.
21. Mamun AA, Lawlor DA, O'Callaghan MJ, et al. Effect of body mass index changes between ages 5 and 14 on blood pressure at age 14: Findings from a birth cohort study. Hypertension 2005, 45:1083-1087.
22. Stamler J, Elliott P, Appel L, et al. Higher blood pressure in middle-aged American adults with less education-role of multiple dietary factors: The InterMAP study. J Hum Hypertens 2003, 17:655-665.
23. Stamler J, Rose G, Elliott P, et al. Findings of the international cooperative InterSALT study. Hypertension 1991, 17(Suppl 1):19-115.
24. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003, 289:2560-2571.
25. Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Hypertension 1999, 34:381-385.
26. Pogue VA, Ellis C, Michel J, Francis CK New staging system of the fifth Joint National Committee Report on The Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V) alters assessment of the severity and treatment of hypertension. Hypertension 1996, 28:713-718.
27. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Hypertension 2001, 37:869-874.
28. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913. Prospective Studies Collaboration.
29. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
30. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557-1562.
31. Kannel WB, Gordon T, Schwartz MJ Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham Study. Am J Cardiol 1971, 27:335-345.
32. Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med 2001, 161:1183-1192.
33. Neaton JD, Wentworth DN Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: Overall findings and differences by age for 316,099 white men. Arch Intern Med 1992, 152:56-64.
34. Neaton JD, Kuller L, Stamler J, Wentworth DN Impact of systolic and diastolic blood pressure on cardiovascular mortality. Hypertension: Pathophysiology, Diagnosis, and Management 1995, 127-144. Raven Press, New York. J.H. Laragh, B.M. Brenner (Eds.).
35. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999, 100:354-360.
36. Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: Factors associated with lack of blood pressure control in the community. Hypertension 2000, 36:594-599.
37. Hyman DJ, Pavlik VN Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001, 345:479-486.
38. Somes GW, Pahor M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999, 159:2004-2009.
39. Lloyd-Jones DM, Evans JC, Larson MG, Levy D Treatment and control of hypertension in the community: A prospective analysis. Hypertension 2002, 40:640-646.
40. Stamler J, Stamler R, Neaton JD Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993, 153:598-615.
41. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297.
42. Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study. Lancet 2001, 358:1682-1686.
43. Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999, 281:634-639.
44. Haider AW, Larson MG, Franklin SS, Levy D Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003, 138:10-16.
45. United States Renal Data System (USRDS) USRDS 2003 Annual Data Report 2003, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
46. Lloyd-Jones DM, Evans JC, Larson MG, et al. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study. Arch Intern Med 1999, 159:2206-2212.
47. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final report. Circulation 2002, 106:3143-3421.
48. Meyer J Age: 2000. Census 2000 Brief 2001, U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau, Washington, DC.
49. Reaven GM Banting lecture 1988: Role of insulin resistance in human disease. Diabetes Care 1988, 37:1595-1607.
50. Reaven GM Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991, 90(Suppl 2A):7S-12S.
51. Kannel WB, Wilson PW, Silbershatz H, D'Agostino RB Epidemiology of risk factor clustering in elevated blood pressure. Multiple Risk Factors in Cardiovascular Disease 1998, 325-333. Kluwer Academic Publishers, New York. A.M. Gotto, C. L'Enfant, R. Paoletti (Eds.).
52. Lloyd-Jones DM, Leip EP, Larson MG, et al. Novel approach to examining first cardiovascular events after hypertension onset. Hypertension 2005, 45:39-45.
53. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994, 271:840-844.
54. Ho KK, Pinsky JL, Kannel WB, Levy D The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993, 22:6A-13A.